Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Targeting of protease activator receptor-2 (PAR-2) antagonist FSLLRY-NH2 as an asthma adjuvant therapy.

Autor: Ocasio-Rivera M, Marin-Maldonado F; Ponce Health Science University, Ponce Puerto Rico., Trossi-Torres G; University of Puerto Rico-Ponce, Ponce Puerto Rico., Ortiz-Rosado A; University of Puerto Rico-Ponce, Ponce Puerto Rico., Rodríguez-Irizarry V; University of Puerto Rico-Ponce, Ponce Puerto Rico., Rodriguez-Lopez E; University of Puerto Rico-Ponce, Ponce Puerto Rico., Martínez S; University of Puerto Rico-Ponce, Ponce Puerto Rico., Almodóvar S; Texas Tech University Health Science Center, Lubbock, TX., Suarez-Martínez E; University of Puerto Rico-Ponce, Ponce Puerto Rico.; Ponce Health Science University, Ponce Puerto Rico.

Publikováno v: Medicine [Medicine (Baltimore)] 2020 Oct 23; Vol. 99 (43), pp. e22351.